XML 14 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
Investment in Joint Ventures (Details) (Medical Joint Venture, USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Medical Joint Venture
   
Schedule Of Equity Method Investments [Line Items]    
Current Assets $ 1,582,415us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
$ 2,258,809us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Non Current Assets 1,593,737us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
1,561,130us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Total Assets 3,176,152us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
3,819,939us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Current Liability 962,655us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
125,962us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Equity 2,213,497us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
3,693,977us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Total Liability and Equity 3,176,152us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
3,819,939us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Operation expenses 1,896,784mlss_EquityMethodInvestmentSummarizedFinancialInformationOperationExpenses
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
1,019,606mlss_EquityMethodInvestmentSummarizedFinancialInformationOperationExpenses
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
Net Loss $ (1,896,784)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember
$ (1,019,606)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= mlss_MedicalJointVentureMember